EKF Diagnostics Holdings plc (LON:EKF - Get Free Report) passed above its two hundred day moving average during trading on Wednesday . The stock has a two hundred day moving average of GBX 24.83 ($0.34) and traded as high as GBX 30.45 ($0.41). EKF Diagnostics shares last traded at GBX 29.60 ($0.40), with a volume of 97,053 shares changing hands.
EKF Diagnostics Price Performance
The company's fifty day moving average is GBX 28.42 and its two-hundred day moving average is GBX 24.93. The firm has a market capitalization of £131.58 million, a price-to-earnings ratio of 2,123.19 and a beta of 0.57. The company has a quick ratio of 1.77, a current ratio of 4.60 and a debt-to-equity ratio of 0.34.
EKF Diagnostics Company Profile
(
Get Free Report)
EKF is an AIM-listed global diagnostics business focussed on:
● Point-of-Care analysers in the key areas of Hematology and Diabetes
● Life Sciences services provide specialist manufacture of enzymes and custom products for use in diagnostic, food and industrial applications.
EKF has headquarters in Penarth (near Cardiff) and operates five manufacturing sites across the US and Germany, selling into over 120 countries world-wide.
See Also
Before you consider EKF Diagnostics, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and EKF Diagnostics wasn't on the list.
While EKF Diagnostics currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Learn the basics of options trading and how to use them to boost returns and manage risk with this free report from MarketBeat. Click the link below to get your free copy.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
